0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Article |

Albuterol Administered by Metered-Dose Inhaler and Spacer to Young Children With Wheezing

Edward R. Carter, MC, USA
Arch Pediatr Adolesc Med. 1994;148(12):1352-1353. doi:10.1001/archpedi.1994.02170120114026.
Text Size: A A A
Published online

The use of a spacer with face mask to administer aerosolized medication to infants and toddlers is controversial. Hickey et al1 evaluated the use of a "homemade" spacer to administer low-dose albuterol (two puffs, or 180 μg given twice, 20 minutes apart) to infants and toddlers presenting to the emergency department with wheezing. The study has problems that make it difficult for me to accept the authors' conclusions that the low dose of albuterol they administered via spacer with face mask to young children presenting to the emergency department with wheezing resuited in significant clinical improvement. I also believe that this study and its conclusions send a wrong message: low-dose albuterol administered via metered-dose inhaler with a spacer (MDI-S) and face mask is an acceptable alternative to standard nebulizer therapy in infants and toddlers. I note the following three major problems with the study: (1) the spacer device employed;

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

Correspondence

CME
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Submit a Comment

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();